Robinson G - Search Results

1

Cloning and mRNA expression of vascular endothelial growth factor in ischemic retinas of Macaca fascicularis.

Shima DT, Gougos A, Miller JW, Tolentino M, Robinson G, Adamis AP, D'Amore PA. Shima DT, et al. Among authors: robinson g. Invest Ophthalmol Vis Sci. 1996 Jun;37(7):1334-40. Invest Ophthalmol Vis Sci. 1996. PMID: 8641836

2

Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice.

Zhong L, Bradley J, Schubert W, Ahmed E, Adamis AP, Shima DT, Robinson GS, Ng YS. Zhong L, et al. Invest Ophthalmol Vis Sci. 2007 Mar;48(3):1212-8. doi: 10.1167/iovs.06-0757. Invest Ophthalmol Vis Sci. 2007. PMID: 17325165

3

Simultaneous but not prior inhibition of VEGF165 enhances the efficacy of photodynamic therapy in multiple models of ocular neovascularization.

Ju M, Mailhos C, Bradley J, Dowie T, Ganley M, Cook G, Calias P, Lange N, Adamis AP, Shima DT, Robinson GS. Ju M, et al. Among authors: robinson gs. Invest Ophthalmol Vis Sci. 2008 Feb;49(2):662-70. doi: 10.1167/iovs.07-0195. Invest Ophthalmol Vis Sci. 2008. PMID: 18235012

4

Synergies of VEGF inhibition and photodynamic therapy in the treatment of age-related macular degeneration.

Zuluaga MF, Mailhos C, Robinson G, Shima DT, Gurny R, Lange N. Zuluaga MF, et al. Among authors: robinson g. Invest Ophthalmol Vis Sci. 2007 Apr;48(4):1767-72. doi: 10.1167/iovs.06-1224. Invest Ophthalmol Vis Sci. 2007. PMID: 17389510

5

Inhibition of platelet-derived growth factor B signaling enhances the efficacy of anti-vascular endothelial growth factor therapy in multiple models of ocular neovascularization.

Jo N, Mailhos C, Ju M, Cheung E, Bradley J, Nishijima K, Robinson GS, Adamis AP, Shima DT. Jo N, et al. Am J Pathol. 2006 Jun;168(6):2036-53. doi: 10.2353/ajpath.2006.050588. Am J Pathol. 2006. PMID: 16723717 Free PMC article.

6

Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury.

Nishijima K, Ng YS, Zhong L, Bradley J, Schubert W, Jo N, Akita J, Samuelsson SJ, Robinson GS, Adamis AP, Shima DT. Nishijima K, et al. Am J Pathol. 2007 Jul;171(1):53-67. doi: 10.2353/ajpath.2007.061237. Am J Pathol. 2007. PMID: 17591953 Free PMC article.

7

An antisense oligodeoxynucleotide against vascular endothelial growth factor in a nonhuman primate model of iris neovascularization.

Bhisitkul RB, Robinson GS, Moulton RS, Claffey KP, Gragoudas ES, Miller JW. Bhisitkul RB, et al. Arch Ophthalmol. 2005 Feb;123(2):214-9. doi: 10.1001/archopht.123.2.214. Arch Ophthalmol. 2005. PMID: 15710818

8

Molecular mapping and functional characterization of the VEGF164 heparin-binding domain.

Krilleke D, DeErkenez A, Schubert W, Giri I, Robinson GS, Ng YS, Shima DT. Krilleke D, et al. J Biol Chem. 2007 Sep 21;282(38):28045-56. doi: 10.1074/jbc.M700319200. Epub 2007 Jul 10. J Biol Chem. 2007. PMID: 17626017 Free article.

9

RGS5 expression is a quantitative measure of pericyte coverage of blood vessels.

Mitchell TS, Bradley J, Robinson GS, Shima DT, Ng YS. Mitchell TS, et al. Angiogenesis. 2008;11(2):141-51. doi: 10.1007/s10456-007-9085-x. Epub 2007 Nov 25. Angiogenesis. 2008. PMID: 18038251

10

Inhibitory effect of an antibody to cryptic collagen type IV epitopes on choroidal neovascularization.

Jo N, Ju M, Nishijima K, Robinson GS, Adamis AP, Shima DT, Mailhos C. Jo N, et al. Mol Vis. 2006 Oct 26;12:1243-9. Mol Vis. 2006. PMID: 17110907 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,208 results

Search Page

Filters